ACADL is a mitochondrial enzyme that is frequently downregulated in hepatocellular carcinoma, and its low expression is significantly associated with poor clinical prognosis in hepatocellular carcinoma patients [36]. Here, ACADL is linked to hepatocellular carcinoma.